SZSE Ticker: 002330

Shandong Delisi Food Co., Ltd.

山东得利斯食品股份有限公司

得利斯

DELISI

Listing Date: 2010-01-06

Board: SME

Industry Classification: Manufacturing

Does the company have biotech-improved food? Delis: The company has no related business_Finance Bay EHZ / Financial Diamond Value Drive

Does the company have biotech-improved food? Delis: The company has no related business_Finance Bay EHZ / Financial Diamond Value Drive

Does the company have biotech-improved food? Delis: The company has no related business_Finance Bay EHZ / Financial Diamond Value Drive

Does the company have biotech-improved food? Delis: The company has no related business_ Oriental Fortune Net

Liu Yongxuan: Will the prefab track be a flash in the pan? _Shenzhen Hotline

Liu Yongxuan: Will the prefab track be a flash in the pan? -Finance-financial world

Liu Yongxuan: Will the prefab track be a flash in the pan? -News Channel-Hexun.com

ESG Weekly Report (Issue 36)丨The Ministry of Industry and Information Technology supports the implementation of major technological transformations for energy conservation and carbon reduction in key areas. Proya admits that there are differences in the quality of star products 21 Economic Net

Nearly 90% of the listed companies in Shandong Province made a profit last year

Huaxin Securities: Give Delis an Overweight Rating_Stock News_Market Gold Online

Revenue has risen for three consecutive years! A year-on-year increase of over 100%! The prefabricated vegetable business of listed companies is "scented", and these two "sects" have more advantages

Delis: The company has a relatively complete market layout and diversified sales models_ Oriental Fortune Net

Delis: At present, the company's production and operation are all normal_Oriental Fortune Net

Suddenly, the popular 100 billion leader lost 3.7 billion in the first quarter, the Omicoron inactivated vaccine entered clinical trials, and Beishang Capital is optimistic about 4 stocks – yqqlm

Suddenly, the popular 100 billion leader lost 3.7 billion in the first quarter. Omicron’s inactivated vaccine enters clinical trials, and Beijing Capital is optimistic about 4 stocks

Suddenly, the popular 100 billion leader lost 3.7 billion in the first quarter of the Omicron inactivated vaccine and entered clinical trials. Beishang Capital is optimistic about 4 stocks

Suddenly, the popular 100 billion leader lost 3.7 billion in the first quarter! Omicron’s inactivated vaccine enters clinical trials, and Beishang capital is optimistic about 4 stocks – yqqlm

Societe Generale Jubao Flexible Allocation Mixed Net Worth Down 3.25% Societe Generale

Institutions, shareholders, and executives scramble to buy these performance-enhancing stocks – yqqlm

Food and Beverage Observation Issue 3: The industry declined the most in the first quarter, and Guangdong launched ten pre-made dishes to seize the industrial highland

[Express] Xingye Jubao Flexible Configuration Mixed Announcement of the Top 10 Heavy Holding Stocks in the First Quarterly Report- CFi.CN Zhongcai Network

Want to see more data? Registered subscribers can see all the data.